Industry news
New weight loss medications are changing the pharmacy landscape
GLP-1 agonists are shifting approaches to weight loss, but what do these promising yet expensive medications mean for patients and plan sponsors?
Latest thought leadership
Article
Biosimilars to save billions in this decade
Drug pipeline report
3 new first-in-class therapies coming
Regulatory update
Which rules will impact pharmacy in 2023?
Insights
Connect your patients to funds and support with FundFinder
Help your patients afford their medications and connect to funds from charitable organizations with FundFinder.
Tools for coping with depression
If you feel you’re struggling with depression, these tools are a starting point to help.
Specialty Pharmacy 101
Specialty pharmacies deliver high-touch services to help patients stay adherent to treatment plans and live healthier lives.
Quick-reference oncology drug guide
This interactive guide makes it easy for prescribers to find the drug information they need to get patients started on their therapy.
Pharmacy Insights Podcast
Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.
Keeping your data secure is mission critical
See how we help prevent costly, disruptive cyberattacks.
3 new drugs to watch this fall
As the year begins to close, we highlight three essential pipeline drugs with an expected U.S. Food and Drug Administration (FDA) decision this fall.
3 ways to deal with escalating drug costs
Innovations custom built for today’s specialty challenges.
Four myths: Carving out specialty pharmacy
Integrating specialty pharmacy means better care, lower costs.
Smart formulary management
Developing and managing formularies that bring clinical and financial value
Creating connections through partnerships
Hear from an Optum Rx client on how we're partnering together for everyone we serve.
Navigating ‘The Great Resignation’
A Q&A about workforce trends, obstacles and solutions
Managing diabetes gains an 8:1 return on investment
Learn how a third-party administrator’s client improved health outcomes and lowered costs.
Optum Rx customer obsession video
How one Optum Rx employee made the system work better for everyone
How to manage medication overload
Hear from a leader's perspective on how to manage polypharmacy.
Will diabetes drugs help us tackle obesity?
Discover four things to know about new uses of GLP-1 drugs.
Specialty drug prices giving you sticker shock?
See how Specialty Compass defuses exploding drug costs.
5 questions: Optum Rx chief pharmacy officer
Michael Einodshofer addresses the risks, challenges and opportunities facing the industry.
How our medication packaging helps the planet
New packaging saves CO2, water, energy, and plastic waste.
Which Rules Will Impact Pharmacy in 2023?
2023 is already a busy year for pharmacy regulation. Read about the latest regulations that could impact you and your pharmacy benefit plan.
Unlocking the promise of personal medicine
See how a peek at your genes enables more precise prescribing.
Outlook on oncology 2023
See how emerging trends, including a global pandemic, are reshaping the landscape of oncology care and medication.
How to control drug costs without compromising care
Explore three principles driving better pharmacy benefit decisions.
Addressing pharmacy issues that matter to you
From specialty pharmacy to drug affordability, our experts tackle your biggest pharmacy challenges.
3 new first-in-class therapies coming
See how innovation is driving the latest product development.
Specialty and Weight Loss Webinar
Hear how weight loss drugs are shaping traditional and specialty spend.
GLP-1 agonists: A new class of weight loss medications
In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.
Biosimilars to save billions in this decade
Prices for popular brand-name biologics drop up to 60% with generic-equivalent biosimilars.
Empowering clients with more choice and transparency
Helping make prescription drugs more affordable for plan sponsors and the members we serve is a universal focus.
Orphan drugs market: Can we afford them?
We examine key questions around orphan drugs such as why they're so expensive, how they're being used and what plan sponsors should do next.
Inflammatory conditions: Trends, pipeline, management strategies
Hear leaders discuss trends for inflammatory conditions and gain insights on how the market is changing with a deep dive on pipeline, biosimilars, and care management strategies.
Gene Therapy: How to Prepare for a Growing Pipeline
The unprecedented cost of gene therapies requires a fundamental rethinking of how treatment costs are managed.
The secret to lowering the total cost of care
Rising pharmacy costs concern everyone. Managing the underlying health conditions behind each prescription is key to addressing these high costs.
What’s changing the PBM industry?
In this conversation, learn from Optum Rx thought leaders on how access, affordability and transparency have become imperatives for pharmacy benefit management.
Rules Impacting Pharmacy: Summer 2023 Legislative Sessions
Learn what's at stake as the Senate considers PBM legislation.
Drugs to Watch in Summer 2023: New Therapies [Report]
New drugs for postpartum depression, dermatitis and blindness are coming.
Disruption and Risk in Health Care
Dr. Wyatt Decker discusses how innovation can be the upside of disruption and the importance of value-based care in changing the status quo.
2023 3rd Annual C-suite Research Report
How are market dynamics impacting decision-making across health care? Research report examines progress, challenges and priorities in 2023.
3 steps to slash medication costs
This is your guide to reducing your health care spending.
The Next Biosimilar Wave Has Arrived. Now What?
In this conversation, learn about a new class of biosimilars and what this means for competition, cost and volume in the PBM market.
7 Strategies for Meeting More Mental Health Needs
Discover how to create an interconnected network of services that help people get properly diagnosed, access support and sustain progress.
Lowest net cost and your bottom line
Learn about strategies to achieve the lowest net cost of prescription drugs through formularies, biosimilars and our Vigilant Drug Program.
Optum Rx Drug Pipeline Insights Reports
Read the most recent quarterly reports on new drugs coming down the pipeline.
Alternative funding: Real savings or problems?
See how much "free" drugs will actually cost you.
Regulations to watch: Fall 2023
Learn what's at stake as the PBM legislation advances on Capitol Hill.
Redefining the prior authorization process
How we are revamping the prescribing process
Personalized care: Focusing on the member
Hear from Optum Rx chief of operations, Jon Mahrt
Defining the future of alternate-site infusion pharmacy care
Optum tackles the many issues infusion pharmacy care faces as it serves vulnerable patients with acute needs and complex conditions.
How to eliminate prescription waste
Achieve savings by targeting expensive, low-value drugs.
Alzheimer’s Treatment: Time for a Level-Set?
See success rates, risks and costs of the new Alzheimer’s treatments.
Case Study: Advanced Pharmacy Audit Services
How a health plan saved more than $1 million
EDI Companion Guide
HIPAA Companion Guides describe Optum Rx specific technical details for EDI transactions.
Top